These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27665509)

  • 1. Prospective study of the impact of diabetes mellitus newly diagnosed by glycated hemoglobin on outcomes in patients undergoing percutaneous coronary intervention.
    Tailakh MA; Friger M; Zahger D; Sidi A; Mazor-Dray E; Novack V
    Eur J Intern Med; 2017 Jan; 37():69-74. PubMed ID: 27665509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Li Y; Li X; Zhang Y; Zhang L; Wu Q; Bai Z; Si J; Zuo X; Shi N; Li J; Chu X
    BMC Cardiovasc Disord; 2020 Jan; 20(1):36. PubMed ID: 32000678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Glycated Hemoglobin for Assessment of Glucose Metabolism in Patients With ST-Segment Elevation Myocardial Infarction.
    Aggarwal B; Shah GK; Randhawa M; Ellis SG; Lincoff AM; Menon V
    Am J Cardiol; 2016 Mar; 117(5):749-53. PubMed ID: 26768673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Long-Term Mortality in Patients With Single Coronary Narrowing and Diabetes Mellitus to That of Patients With Multivessel Coronary Narrowing Without Diabetes Mellitus.
    Omair M; Koshy AN; Dinh DT; Brennan AL; Reid CM; Ajani AE; Duffy SJ; Farouque O; Yudi MB; Clark DJ
    Am J Cardiol; 2021 Mar; 142():1-4. PubMed ID: 33285090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, Predictors, and Clinical Outcomes of New-Onset Diabetes Mellitus after Percutaneous Coronary Intervention with Drug-Eluting Stent.
    Chun KH; Im E; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    J Korean Med Sci; 2017 Oct; 32(10):1603-1609. PubMed ID: 28875603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of elevated HbA1c on long-term mortality in patients presenting with acute myocardial infarction in daily clinical practice: insights from a 'real world' prospective registry of the Zwolle Myocardial Infarction Study Group.
    Hermanides RS; Kennedy MW; Kedhi E; van Dijk PR; Timmer JR; Ottervanger JP; Dambrink JH; Gosselink AM; Roolvink V; Miedema K; Slingerland RJ; Koopmans P; Bilo HJ; van 't Hof AW
    Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):616-625. PubMed ID: 31124695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention.
    Sharma PK; Agarwal S; Ellis SG; Goel SS; Cho L; Tuzcu EM; Lincoff AM; Kapadia SR
    Circ Cardiovasc Interv; 2014 Aug; 7(4):503-9. PubMed ID: 25097197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of body mass index on long-term outcomes in patients undergoing percutaneous coronary intervention stratified by diabetes mellitus: a retrospective cohort study.
    Rao C; Zhong Q; Wu R; Li Z; Duan Y; Zhou Y; Wang C; Chen X; Wang R; He K
    BMC Cardiovasc Disord; 2024 Feb; 24(1):113. PubMed ID: 38365597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction.
    Cicek G; Uyarel H; Ergelen M; Ayhan E; Abanonu GB; Eren M; Gibson CM
    Coron Artery Dis; 2011 May; 22(3):131-7. PubMed ID: 21394027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of initial glycosylated hemoglobin level on cardiovascular outcomes in prediabetic patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shin D; Ahn J; Cha KS; Park JS; Oh JH; Lee HW; Hong JY; Kim BW; Hong TJ;
    Coron Artery Dis; 2016 Jan; 27(1):40-6. PubMed ID: 26398151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusion.
    Ahn J; Hong TJ; Park JS; Lee HW; Oh JH; Choi JH; Lee HC; Cha KS; Yun E; Jeong MH; Chae SC; Kim YJ; Hur SH; Seong IW; Jang YS; Cho MC; Kim CJ; Seung KB; Rha SW; Bae JH; Park SJ;
    Coron Artery Dis; 2015 Nov; 26(7):555-61. PubMed ID: 25933028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic Control Status After Percutaneous Coronary Intervention and Long-Term Clinical Outcomes in Patients With Type 2 Diabetes Mellitus.
    Hwang JK; Lee SH; Song YB; Ahn J; Carriere K; Jang MJ; Park TK; Choi SH; Yang JH; Choi JH; Lee SH; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28373177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).
    Ertelt K; Brener SJ; Mehran R; Ben-Yehuda O; McAndrew T; Stone GW
    Am J Cardiol; 2017 Jun; 119(12):1917-1923. PubMed ID: 28427734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline plasma fibrinogen is associated with haemoglobin A1c and 2-year major adverse cardiovascular events following percutaneous coronary intervention in patients with acute coronary syndrome: a single-centre, prospective cohort study.
    Zhang L; Xu C; Liu J; Bai X; Li R; Wang L; Zhou J; Wu Y; Yuan Z
    Cardiovasc Diabetol; 2019 Apr; 18(1):52. PubMed ID: 31014348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Safety and Efficacy of Staged Percutaneous Coronary Intervention for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
    Am J Cardiol; 2019 Aug; 124(3):334-342. PubMed ID: 31174834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of the combination of age, creatinine, and ejection fraction score and diabetes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Gao S; Liu Q; Ding X; Chen H; Zhao X; Li H
    Coron Artery Dis; 2020 Mar; 31(2):109-117. PubMed ID: 31464730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of Stature to Outcomes in Korean Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (from the INTERSTELLAR Registry).
    Moon J; Suh J; Oh PC; Lee K; Park HW; Jang HJ; Kim TH; Park SD; Kwon SW; Kang WC
    Am J Cardiol; 2016 Jul; 118(2):177-82. PubMed ID: 27236252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly diagnosed diabetes has high risk for cardiovascular outcome in ischemic stroke patients.
    Cho KH; Kwon SU; Lee JS; Yu S; Cho AH
    Sci Rep; 2021 Jun; 11(1):12929. PubMed ID: 34155277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.